News & Events
June 2009 - Newsletter
Jun 2009 - NewslettersDownload the file »
Preventing Cervical Cancer: Integrating Screening and Vaccination (March 2009)
Mar 2009 - News
The Victorian Cytology Service Inc (VCS), in association with the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), was proud to be the organiser of Preventing Cervical Cancer 2009: Integrating Screening and Vaccination (PCC2009).
PCC2009 brought together international and Australian experts in cervical screening, vaccination and cancer epidemiology to debate and explore current and future directions in the prevention of cervical cancer. It provided a forum for these experts to share their vision and influence policy development in the prevention of cervical cancer.
Australia’s cervical screening program is amongst the most successful in the world. Now, coupled with our world-leading commitment to population-based vaccination for high-risk HPV, Australia is poised to develop highly effective new models for cervical cancer prevention that could eventually lead to the almost total eradication of this disease.
December 2008 - Newsletter
Dec 2008 - NewslettersDownload the file »
Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2003 to 2006
Jun 2008 - News
This is the second NCIRS publication focusing on Aboriginal and Torres Strait Islander people. It includes the latest detailed data on nine major vaccine preventable diseases, as well as vaccination coverage in children and adults. This publication is now available at the Communicable Diseases Intelligence website.
April / May 2008 - Newsletter
Apr 2008 - NewslettersDownload the file »
TGA statement on Gardasil adverse events
Dec 2007 - News
The Theraputic Goods Administration released a summary of reported adverse events following the distribution of over 2.2 million doses of the human papillomavirus vaccine in Australia.
[This statement has since been updated on the Therapeutic Goods Administration website.]
December 2007 - Newsletter
Dec 2007 - NewslettersDownload the file »
October 2007 - Newsletter
Oct 2007 - NewslettersDownload the file »
SEMINAR: Developing and communicating about immunisation policy - the bit we don't talk about (September 2007)
Sep 2007 - News
This seminar was given by Professor David M Salisbury CB FRCP FRCPCH FFPH, Director of Immunisation, Department of Health, United Kingdom.
The development of immunisation policy in the UK is similar to the model of other industrialised countries: an independent expert advisory committee reviews evidence that it receives, makes recommendations to the Government and these are applied throughout the UK. Where there are differences are in the arrangements for management of the program.
A team of around 20 individuals within the Department of Health manages the strategy development and implementation. Their work spans the bringing together of scientific evidence, the purchase, supply and distribution arrangements for vaccines, the informatics systems for the immunisation program and the communications work that informs and supports immunisation implementation.
The UK program uses the usual process and outcome measurements that are routine (coverage and disease surveillance) but also monitors public knowledge and attitudes about immunisation with equal priority. Given the extent of investment especially in new vaccines, it is of increasing importance that consumer attitudes are monitored and reflected in program management. This aspect of program management requires skills specific to the task and that should be integral within national programs.
Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005
Jun 2007 - News
NCIRS is proud to announce the publication of Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005, which is the fourth national report into Australia’s progress in preventing diseases through vaccination.
The report provides an overview of the 16 diseases preventable by currently available vaccines. These include the 12 for which vaccines were funded nationally for children by the end of 2005 (diphtheria, Haemophilus influenzae type b (Hib) disease, hepatitis B, invasive pneumococcal disease, measles, meningococcal C disease, mumps, pertussis, poliomyelitis, rubella, tetanus and varicella), and another 3 vaccines only funded or recommended for specific high-risk groups (hepatitis A, influenza and Q fever). Rotavirus, for which new vaccines became available in 2006, is also included.
The report can be found at the Communicable Diseases Intelligence website.
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next